Sabiporide Reduces Ischemia-Induced Arrhythmias and Myocardial Infarction and Attenuates ERK Phosphorylation and iNOS Induction in Rats

The aim of the present study was to investigate the effects of sabiporide, a potent and selective NHE1 inhibitor, on myocardial ischemia-induced arrhythmias and myocardial infarction and the possible pathways related to the cardioprotection afforded by sabiporide treatment. Anesthetized rats were subjected to myocardial ischemia via left main coronary artery occlusion for 30 minutes, followed by 2 hours of reperfusion. Administration of sabiporide (0.01–3.0 mg/kg) prior to coronary artery occlusion dose-dependently reduced ischemia-induced arrhythmias and infarct size with an ED50 value of 0.14 mg/kg. Administration of sabiporide (1.0 mg/kg) prior to reperfusion also reduced infarct size by 38.6%. The reduction in infarct size was accompanied by a decrease in circulating levels of creatine phosphokinase and troponin I. In addition, sabiporide (1.0 mg/kg) given prior to coronary artery occlusion or immediately before reperfusion significantly reduced phosphorylation of the extracellular signal-regulated kinase (ERK1/2) and the expression of the inducible nitric oxide synthase (iNOS) following myocardial ischemia-reperfusion. This study demonstrates that sabiporide is a potent and effective cardioprotective agent during myocardial ischemia and reperfusion, by reducing serious ventricular arrhythmias and myocardial infarct size. The cardioprotection afforded by sabiporide is attributed in part to inhibition of ERK1/2 phosphorylation and suppression of iNOS expression.

[1]  Dongwon Lee,et al.  Protective effects of NHE1 inhibition with sabiporide in an experimental model of asphyxia-induced cardiac arrest in piglets. , 2013, Resuscitation.

[2]  P. Heusch,et al.  The contribution of reactive oxygen species and p38 mitogen‐activated protein kinase to myofilament oxidation and progression of heart failure in rabbits , 2010, British journal of pharmacology.

[3]  M. Galinier,et al.  Arythmies ventriculaires, mort subite et insuffisance cardiaque , 2010 .

[4]  W. Abraham,et al.  Resuscitation with Na+/H+ exchanger inhibitor in traumatic haemorrhagic shock: Cardiopulmonary performance, oxygen transport and tissue inflammation , 2010, Clinical and experimental pharmacology & physiology.

[5]  J. Zweier,et al.  Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production. , 2010, Archives of biochemistry and biophysics.

[6]  H. Duff,et al.  iNOS in cardiac myocytes plays a critical role in death in a murine model of hypertrophy induced by calcineurin. , 2008, American journal of physiology. Heart and circulatory physiology.

[7]  S. Javadov,et al.  The role of NHE-1 in myocardial hypertrophy and remodelling. , 2008, Journal of molecular and cellular cardiology.

[8]  D. Kintner,et al.  ERK1/2-p90RSK-mediated Phosphorylation of Na+/H+ Exchanger Isoform 1 , 2007, Journal of Biological Chemistry.

[9]  Jose A. Adams,et al.  Na+/H+ EXCHANGE INHIBITION DELAYS THE ONSET OF HYPOVOLEMIC CIRCULATORY SHOCK IN PIGS , 2007, Shock.

[10]  G. Heusch,et al.  Inhibition of Na+/H+‐exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial β‐adrenoceptor system in failing rabbit hearts , 2006, British journal of pharmacology.

[11]  K. Yi,et al.  Effects of sabiporide, a specific Na+/H+ exchanger inhibitor, on neuronal cell death and brain ischemia , 2005, Brain Research.

[12]  M. Karmazyn,et al.  The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention. , 2005, Current drug targets. Cardiovascular & haematological disorders.

[13]  D. Maass,et al.  Sodium/hydrogen exchange activity in sepsis and in sepsis complicated by previous injury: 31P and 23Na NMR study* , 2005, Critical care medicine.

[14]  G. Heusch,et al.  Inhibition of the Na+/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits. , 2004, Cardiovascular research.

[15]  A. K. Snabaitis,et al.  Stimulation of the Plasma Membrane Na+/H+ Exchanger NHE1 by Sustained Intracellular Acidosis , 2003, Journal of Biological Chemistry.

[16]  V. Tanneur,et al.  Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects. , 2003, European journal of pharmacology.

[17]  R. Murtazina,et al.  Functional Analysis of Polar Residues Important for Activity of Na+/H+ Exchangers , 2002, Annals of the New York Academy of Sciences.

[18]  H. Drexler,et al.  Regulation of Cardiac Remodeling by Nitric Oxide: Focus on Cardiac Myocyte Hypertrophy and Apoptosis , 2002, Heart Failure Reviews.

[19]  D. Stewart,et al.  Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. , 2002, The Journal of clinical investigation.

[20]  R. Khalil,et al.  Endothelin-1–Induced Enhancement of Coronary Smooth Muscle Contraction via MAPK-Dependent and MAPK-Independent [Ca2+]i Sensitization Pathways , 2002 .

[21]  A J Camm,et al.  Ischaemic heart disease presenting as arrhythmias. , 2001, British medical bulletin.

[22]  M. Karmazyn,et al.  Activation of Na+/H+ Exchanger-directed Protein Kinases in the Ischemic and Ischemic-reperfused Rat Myocardium* , 2001, The Journal of Biological Chemistry.

[23]  A. Takashima,et al.  Involvement of iNOS in postischemic heart dysfunction of stroke-prone spontaneously hypertensive rats. , 2001, American journal of physiology. Heart and circulatory physiology.

[24]  J. Stassen,et al.  Effects of BIIB513 on ischemia-induced arrhythmias and myocardial infarction in anesthetized rats , 2000, Basic Research in Cardiology.

[25]  G. Gross,et al.  Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation. , 2000, European journal of pharmacology.

[26]  P. Cannon,et al.  Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture. , 1999, American journal of physiology. Heart and circulatory physiology.

[27]  L. Fliegel.  Functional and Cellular Regulation of the Myocardial Na+/H+ Exchanger , 1999, Journal of Thrombosis and Thrombolysis.

[28]  A. K. Snabaitis,et al.  Regulation of Cardiac Sarcolemmal Na+/H+ Exchanger Activity: Potential Pathophysiological Significance of Endogenous Mediators and Oxidant Stress , 1999, Journal of Thrombosis and Thrombolysis.

[29]  Shokei Kim,et al.  Activation of mitogen-activated protein kinases in in vivo ischemia/reperfused myocardium in rats. , 1999, Journal of molecular and cellular cardiology.

[30]  G. Kojda,et al.  Regulation of basal myocardial function by NO. , 1999, Cardiovascular research.

[31]  M. Karmazyn,et al.  Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. , 1999, American journal of physiology. Heart and circulatory physiology.

[32]  A. Clerk,et al.  Stimulation of “Stress-regulated” Mitogen-activated Protein Kinases (Stress-activated Protein Kinases/c-Jun N-terminal Kinases and p38-Mitogen-activated Protein Kinases) in Perfused Rat Hearts by Oxidative and Other Stresses* , 1998, The Journal of Biological Chemistry.

[33]  Y. Zou,et al.  Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. , 1997, The Journal of clinical investigation.

[34]  B. Reichart,et al.  Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction. , 1997, Circulation.

[35]  T. Taniguchi,et al.  Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. , 1994, Science.

[36]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[37]  M. Karmazyn,et al.  Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. , 1993, Cardiovascular research.

[38]  W. Linz,et al.  Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia , 1993, British journal of pharmacology.

[39]  K. Benndorf,et al.  Reoxygenation-induced arrhythmogenic transient inward currents in isolated cells of the guinea-pig heart , 1991, Pflügers Archiv.

[40]  R. Campbell,et al.  The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. , 1988, Cardiovascular research.

[41]  A. Lukas,et al.  Possible Mechanisms of Ventricular Arrhythmias Elicited by Ischemia followed by Reperfusion Studies on Isolated Canine Ventricular Tissues , 1985, Circulation research.

[42]  E. Braunwald,et al.  Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. , 1983, Circulation.

[43]  Reimer Ka,et al.  The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. , 1979 .

[44]  J. Albenque,et al.  [Ventricular arrhythmias, sudden death and heart failure]. , 2010, Bulletin de l'Academie nationale de medecine.

[45]  S. Umar,et al.  Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart , 2009, Molecular and Cellular Biochemistry.

[46]  R. Khalil,et al.  Endothelin-1--induced enhancement of coronary smooth muscle contraction via MAPK-dependent and MAPK-independent [Ca(2+)](i) sensitization pathways. , 2002, Hypertension.

[47]  P. Corr,et al.  Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis. , 1995, Herz.

[48]  D. Royston,et al.  Reperfusion injury. , 1991, Critical care nursing clinics of North America.

[49]  M. Weisfeldt,et al.  Reperfusion injury. , 1988, Free radical biology & medicine.

[50]  E. Braunwald,et al.  Coronary reperfusion for the treatment of acute myocardial infarction: postischemic ventricular dysfunction. , 1983, Cardiology.